Insulin and Equipment Shortages in Gaza: A Lethal Crisis for Diabetes Patients
The ongoing war and blockade in Gaza have created a dire shortage of insulin, glucose meters, and test strips, placing tens of thousands of diabetes patients at extreme risk. For patients, the struggle to secure life-saving medication has become a daily battle, often with fatal consequences.
The ongoing conflict and blockade in Gaza have devastated the region's healthcare system, creating a life-threatening crisis for patients with diabetes. As medical supplies dwindle and access to essential care collapses, individuals like 20-year-old Hamza al-Ghazali are fighting a daily battle not just against war, but against a chronic condition that requires strict, uninterrupted management. The shortage of insulin, glucose meters, and test strips has transformed a manageable disease into a lethal threat.
Before the war, Hamza could reliably obtain insulin from local pharmacies at an affordable price. The cost of a single insulin pen ranged between 25 and 35 shekels ($8.5 and $12). He had established relationships with pharmacists who knew his condition, making his treatment a routine part of life. However, the tightening of Israeli restrictions on the entry of medicines and medical supplies since October 2023 has completely upended this stability. The price of a single insulin pen has skyrocketed to between 75 and 100 shekels ($25 and $34), and Hamza requires six to seven pens per month. This price surge has forced him to ration his supply, extending the use of each pen for as long as possible, which is a dangerous gamble with his life.
The Dire Reality of Insulin Scarcity
For Type 1 diabetes patients, insulin is not a luxury but a necessity. Delaying or skipping doses can lead to dangerously high blood sugar levels, resulting in severe complications such as diabetic ketoacidosis, a life-threatening emergency. The scarcity of insulin in Gaza has placed patients in a constant state of crisis. Hamza describes the impossible choice he faces: eating too much without sufficient insulin can spike his blood sugar, while eating too little to conserve his supply can cause dangerous hypoglycemia (low blood sugar). He said, "I was living between two fears all the time." During the siege of northern Gaza, his fear was not just of bombs, but of dying from low blood sugar while trapped under rubble.
The Collapse of Monitoring and Testing
The shortage extends beyond insulin to the very tools needed to manage the disease. Glucose meters, which cost between 250 and 300 shekels ($85 and $120), are only useful if test strips are available. These strips have become critically scarce, forcing patients like Hamza to rely on physical symptoms rather than objective data to gauge their blood sugar levels. He estimates that more than 80 percent of diabetes patients in some areas are unable to test their blood sugar regularly, a situation he describes as a "medical disaster." Without monitors, treatment becomes guesswork, increasing the risk of both hyperglycemia and hypoglycemia. The need for test strips is so acute that some patients are forced to buy new devices repeatedly, hoping to find a batch with functioning strips, a costly and futile cycle.
The Impact of Improper Storage and Expired Medication
The crisis is compounded by the collapse of the supply chain. With power outages and the destruction of medical infrastructure, the proper storage of insulin, which requires refrigeration, has become nearly impossible. Endocrinology specialist Dr. Adli al-Ghouti warns that insulin that has been stored improperly or is expired can lose its effectiveness. This creates a false sense of security, as the patient may take what they believe is a full dose, but their blood sugar remains uncontrolled. Dr. al-Ghouti stated, "Taking an expired dose of insulin may cause significant harm inside the body, while giving a temporary impression of improvement." This hidden danger adds another layer of risk to an already desperate situation.
A Wider Health Catastrophe
The crisis affects a significant portion of Gaza's population. According to the Palestinian Ministry of Health in Gaza, between 70,000 and 80,000 diabetes patients are at risk. This number includes approximately 2,500 children living with Type 1 diabetes, whose condition is particularly fragile during war. The lack of access to proper nutrition, combined with the stress of conflict, further destabilizes blood sugar levels. The collapse of medical follow-up services means that patients have no professional guidance to adjust their treatment in response to changing conditions, leaving them to navigate the crisis alone. The combination of insulin shortages, lack of testing equipment, poor nutrition, and unsafe storage conditions has turned diabetes from a manageable chronic illness into a daily struggle for survival.
The Urgent Need for Action
The situation in Gaza underscores the critical importance of unhindered humanitarian access for medical supplies. The stories of patients like Hamza are a stark reminder that war does not discriminate, but it disproportionately affects the most vulnerable. The international community must prioritize the delivery of insulin, test strips, and glucose meters to prevent a further catastrophic loss of life. Without immediate and sustained intervention, the death toll from preventable diabetic complications will continue to rise, compounding the tragedy of the conflict itself.
